Epigenetic Silencing of TH1-type Chemokines Shapes Tumour Immunity and Immunotherapy

Nature - United Kingdom
doi 10.1038/nature15520
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Epigenetic Control of Immunity

Cold Spring Harbor perspectives in biology
BiochemistryGeneticsMolecular Biology
2014English

Chemokines and Chemokine Receptors: New Targets for Cancer Immunotherapy

Frontiers in Immunology
AllergyImmunology
2019English

Epigenetic Chromatin Silencing: Bistability and Front Propagation

Physical Biology
Cell BiologyStructural BiologyMolecular BiologyBiophysics
2007English

Combining Epigenetic and Immunotherapy to Combat Cancer

Cancer Research
Cancer ResearchOncology
2016English

Telomeric Trans-Silencing: An Epigenetic Repression Combining RNA Silencing and Heterochromatin Formation

PLoS Genetics
EvolutionEcologyGeneticsMolecular BiologyCancer ResearchSystematicsBehavior
2005English

GAD-alum Immunotherapy in Type 1 Diabetes Expands Bifunctional Th1/Th2 Autoreactive CD4 T Cells

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2020English

Chemokines in the Cancer Microenvironment and Their Relevance in Cancer Immunotherapy

Nature Reviews Immunology
MedicineAllergyImmunology
2017English

Immunotherapy and Epigenetic Pathway Modulation in Glioblastoma Multiforme

Frontiers in Oncology
Cancer ResearchOncology
2018English

Epigenetic Dysfunction in T Cells Is Associated With Enhanced Type-2 and Blunted Regulatory Immunity

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy